ArticleScientific reports2025
Nonlinear association of serum copper-zinc ratio with overweight/obesity in children and adolescents.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Serum zinc, copper status and Cu/Zn ratio in overweight and obesity: associations with oxidative stress, adipokines, and cardiometabolic traits in adult women.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026Article
- Nutritional Status in Obesity: A Comprehensive Narrative Review of Dysbiosis, Micronutrient Deficiencies and the Effects of Probiotics/Synbiotics.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity in children and adolescents has become a serious global public health problem and is closely associated with a range of metabolic diseases. Copper and zinc, as important trace elements, play important roles in energy metabolism, oxidative stress, and lipid metabolism, respectively. An imbalance in the copper-to-zinc ratio may be associated with obesity, but its relationship with obesity in children and adolescents has not been fully explored. The present study explored and revealed the association between the two. This study used data from the National Health and Nutrition Examination Survey (NHANES) between 2011 and 2016, including 1730 children and adolescents aged 6 to 19 years. First, the baseline characteristics of all participants were compared. Subsequently, the association between serum copper-zinc ratio and overweight/obesity was explored by multivariate logistic regression modeling. Next, five subgroup analyses were conducted for gender, age, race, household income, and smoking. Finally, threshold effects were assessed using restricted cubic spline regression analysis and segmented regression modeling. Serum copper-zinc ratio was significantly and positively associated with overweight/obesity in children and adolescents, suggesting a potential relationship (OR = 3.06; 95% CI 2.41-3.92; P < 0.001). Subgroup analyses indicated that the correlations were generally stable and consistent, with significant interactions for race and family income. The prevalence of overweight/obesity increased progressively with increasing copper-zinc ratios. However, this trend was nonlinear, clarifying that a serum copper-zinc ratio of 1.561 was a significant inflection point in this nonlinear relationship. This study explores the association between serum copper-zinc ratio and overweight/obesity in children and adolescents, revealing a nonlinear relationship and its threshold effect. As a measure of oxidative stress and lipid metabolism imbalance, the serum copper-zinc ratio may become a new tool for obesity risk assessment. Given its close association with obesity, the serum copper-zinc ratio should be incorporated into child and adolescent health management for early intervention in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.